Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

10843	Companies
235453	Keywords
164399	Articles
126163	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 10/16/2025 at 06:30, 10 months 1 day ago

Actor Pharmaceuticals and Megalabs become partners for the commercialization of Formycon’s Eylea® biosimilar FYB203 (aflibercept) for Australia and Latin America
Actor Pharmaceuticals and Megalabs to commercialize Formycon's Eylea biosimilar FYB203 in Australia and Latin America. Partnership agreements include upfront payments and royalties

Partnerships Commercialization Biosimilar Formycon Eylea
BRIEF

published on 10/02/2025 at 06:35, 10 months 15 days ago

Formycon Secures U.S. License for Aflibercept Biosimilar

Formycon AG U.S. Market Launch Aflibercept Biosimilar Regeneron Agreement Patent Dispute Resolution
BRIEF

published on 10/02/2025 at 06:35, 10 months 15 days ago

Formycon obtient une licence américaine pour le biosimilaire d'Aflibercept

Formycon AG Lancement Sur Le Marché Américain Biosimilaire D'Aflibercept Accord Regeneron Résolution Des Litiges En Matière De Brevets
PRESS RELEASE

published on 10/02/2025 at 06:30, 10 months 15 days ago

Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron
Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron. Commercial launch expected in Q4/2026

Formycon Regeneron Valorum Biologics Aflibercept Biosimilar Patent Disputes
BRIEF

published on 09/17/2025 at 16:00, 11 months ago

Formycon AG : Recherche et prévisions de performance actualisées

Prévisions De Revenus Formycon FYB202 Biosimilaires FYB206
BRIEF

published on 09/17/2025 at 16:00, 11 months ago

Formycon AG: Updated Research and Performance Forecast

Revenue Forecast Biosimilars Formycon FYB202 FYB206
PRESS RELEASE

published on 09/17/2025 at 15:55, 11 months ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH updates rating on Formycon AG (ISIN: DE000A1EWVY8) to Buy with a target price of €48. Analyst expects revenue to rebound in H2 and Q4 due to FYB202 and FYB206 developments

First Berlin Equity Research BUY Rating Formycon AG Update Target Price
BRIEF

published on 09/17/2025 at 06:35, 11 months ago

Horus Pharma Joins Formycon's Eylea® Biosimilar Commercialization

Commercialization Biosimilar Formycon Baiama Horus Pharma
BRIEF

published on 09/17/2025 at 06:35, 11 months ago

Horus Pharma rejoint la commercialisation du biosimilaire Eylea® de Formycon

Commercialisation Formycon Biosimilaire Baiama Horus Pharma
PRESS RELEASE

published on 09/17/2025 at 06:30, 11 months ago

Horus Pharma becomes additional commercialization partner for Formycon's Eylea® biosimilar FYB203 in selected European countries under the brand name Baiama®
Horus Pharma partners with Formycon for Eylea biosimilar commercialization in Europe under Baiama brand. Agreement includes upfront payments and royalties for Klinge. Aflibercept treats nAMD

Agreement Formycon Eylea Biosimilar Horus Pharma Baiama Brand

Accesswire

Published on 08/17/2026 at 15:00, 4 hours 42 minutes ago

Norsemont Appoints Ariel Tepperman to Its Board
Published on 08/17/2026 at 14:30, 5 hours 12 minutes ago

Alset AI Completes Sale of 9.9% Interest in Lyken AI Computing to FingerMotion
Published on 08/17/2026 at 14:00, 5 hours 42 minutes ago

FaZe Esports, a GameSquare Company, Wins Rainbow Six Championship at 2026 Esports World Cup
Published on 08/17/2026 at 14:00, 5 hours 42 minutes ago

Orogen Royalties and Aurum Discovery form Generative Alliance in Norway
Published on 08/17/2026 at 13:00, 6 hours 42 minutes ago

Eagle Plains Samples up to 269g/t Au at the Pine Channel Gold Project, Saskatchewan

View all ACCESSWIRE

EQS Group

Published on 08/17/2026 at 19:00, 42 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 10 AOUT 2026 au 14 AOUT 2026
Published on 08/17/2026 at 18:50, 51 minutes ago

Holding(s) in Company
Published on 08/17/2026 at 17:50, 1 hour 52 minutes ago

EvoNext Holdings SA confirms advanced discussions on a reverse merger with Ascend Sport Technology AG
Published on 08/17/2026 at 17:47, 1 hour 54 minutes ago

Key Figures 15.08.2026
Published on 08/17/2026 at 17:45, 1 hour 57 minutes ago

Press release: Information on Leonteq's shareholder base

Les Echos

Published on 08/17/2026 at 17:45, 1 hour 57 minutes ago

Weekly share buyback
Published on 08/17/2026 at 17:45, 1 hour 57 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 08/17/2026 at 17:40, 2 hours 2 minutes ago

Infotel : Déclaration des transactions sur actions propres réalisées du 10 au 14 août 2026 dans le cadre du programme de rachat d’actions.
Published on 08/17/2026 at 14:19, 5 hours 22 minutes ago

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Published on 08/17/2026 at 09:59, 9 hours 43 minutes ago

260817 BENETEAU Transaction sur actions propres

View all LES ECHOS COMFI WIRE